Japanese chest physicians face hopes and enigmas of gefitinib, a molecular targeting drug for lung cancer.
Nukiwa
Toshihiro
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib